Dr. Lori Pierce on the Impact of BRCA1/2 Mutations on Breast Cancer Treatment Decisions

Lori J. Pierce, MD, professor, Radiation Oncology, University of Michigan School of Medicine, discusses the difficulty of determining the most appropriate treatment for patients with breast cancer who have a mutation in BRCA1 or BRCA2. For more breast cancer information, visit http://www.onclive.com/specialty/brea...